Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...
Andrea Kasinski’s lab is developing a longer-lasting microRNA-34a designed to suppress multiple cancer-driving genes.
Armatus has published data in Molecular Therapy Nucleic Acids describing TVR110, a first-in-class vectorized microRNA for CMT1A.
Andrea Kasinski receives funding from the National Institutes of Health, Department of Defense, and the American Lung Association. Kasinski is also the inventor on multiple patients associated with ...
The Nobel Assembly at the Karolinska Institute has taken a liking to RNA. The committee has awarded two American biologists the 2024 Nobel Prize in Physiology or Medicine for their discovery of ...
A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported Monday (Sept. 4 ...
A diagnostic panel incorporating let-7a-5p, miR-9-5p, and miR-31-5p achieved an area under the curve of 0.862 in differentiating patients with pulmonary arterial hypertension from healthy people.
Researchers have identified microRNA-93 as a key genetic driver of fatty liver disease and discovered that vitamin B3 can effectively shut it down. This finding suggests a safe, widely available ...
Andrea Kasinski receives funding from the National Institutes of Health, Department of Defense, and the American Lung Association. She is the inventor on multiple patients associated with her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results